Source: Medical Device Network

TherOx: TherOx's new heart attack therapy secures FDA approval

TherOx has received premarket approval from the US Food and Drug Administration (FDA) for its SuperSaturated Oxygen (SSO2) therapy to...Read More...The post TherOx's new heart attack therapy secures FDA approval appeared first on Verdict Medical Devices.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Kevin T. Larkin's photo - President & CEO of TherOx

President & CEO

Kevin T. Larkin

CEO Approval Rating

87/100

Read more